TCG Crossover GP II, LLC - 10 Oct 2025 SCHEDULE 13G Report for Monte Rosa Therapeutics, Inc. Common Stock, par value $0.0001 per share (GLUE)

Filing Manager
TCG Crossover GP II, LLC
Reporting Manager
Chen Yu
Security
Monte Rosa Therapeutics, Inc. Common Stock, par value $0.0001 per share
Symbol
GLUE
Shares outstanding
61,495,903 shares
Disclosed Ownership
4,427,705 shares
Ownership
7.2%
Form type
SCHEDULE 13G
Filing time
17 Oct 2025, 16:29:25 UTC
Date of event
10 Oct 2025
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"TCG Crossover GP II, LLC disclosed 7.2% ownership in Monte Rosa Therapeutics, Inc. Common Stock, par value $0.0001 per share (GLUE) on 10 Oct 2025."

Quick Takeaways

  • TCG Crossover GP II, LLC filed SCHEDULE 13G for Monte Rosa Therapeutics, Inc. Common Stock, par value $0.0001 per share (GLUE).
  • Disclosed ownership: 7.2%.
  • Date of event: 10 Oct 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 17 Oct 2025, 16:29.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (5)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
TCG Crossover GP II, LLC 3.6% 2,213,853 0 2,213,853 /s/ Craig Skaling Craig Skaling, Authorized Signatory
TCG Crossover Fund II, L.P. 3.6% 2,213,853 0 2,213,853 /s/ Craig Skaling Craig Skaling, Authorized Signatory
TCG Crossover GP III, LLC 3.6% 2,213,852 0 2,213,852 /s/ Craig Skaling Craig Skaling, Authorized Signatory
TCG Crossover Fund III, L.P. 3.6% 2,213,852 0 2,213,852 /s/ Craig Skaling Craig Skaling, Authorized Signatory
Chen Yu 7.2% 4,427,705 0 4,427,705 /s/ Craig Skaling Craig Skaling, as Attorney-in-Fact for Chen Yu

Sponsored